<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Breast cancer":4,
"Cowden syndrome":1,
"PTEN":1,
"PTEN hamartoma tumor syndrome":1,
"Papillary carcinoma":3,
"Sistrunk’s procedure":1,
"Thyroglossal cyst":1,
"Total thyroidectomy":1,
"Bethesda":1,
"aggressive variant":1,
"columnar variant":1,
"diffuse sclerosing variant":1,
"papillary thyroid carcinoma":13,
"tall cell variant":1,
"Cause of detection":1,
"Outcome":1,
"Screening":2,
"Thyroid cancer":26,
"ACTH = adrenocorticotropic hormone":1,
"DI = diabetes insipidus":1,
"EOR = extent of resection":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"GTR = gross-total resection":1,
"IGF-1 = insulin-like growth factor 1":1,
"LH = luteinizing hormone":1,
"PRL = prolactin":1,
"TSH = thyroid-stimulating hormone":1,
"adenoma":1,
"craniotomy":1,
"endonasal endoscopic":1,
"pituitary surgery":1,
"pituitary tumor":1,
"reoperation":1,
"skull base":1,
"transsphenoidal":1,
"Indeterminate":2,
"TIRADS":1,
"Thyroid nodule":6,
"Ultrasonography":7,
"Autofluorescence":1,
"Near-infrared light":1,
"Parathyroid glands":1,
"Parathyroidectomy":1,
"aspiration cytology":1,
"micropapillary growth":1,
"small papillary cluster":1,
"solid variant":1,
"thyroid":16,
"Benign thyroid nodule":1,
"Complications":1,
"Radiofrequency ablation":1,
"Recurrent thyroid cancer":1,
"Ultrasound":6,
"CYTOPATHOLOGY":2,
"exercise-induced arterial hypoxemia":1,
"hypothyroidism":2,
"lung fibrosis":1,
"radioiodine therapy":3,
"Cardiovascular risk":1,
"Differentiated thyroid cancer":4,
"NT-proBNP":1,
"Anti-thyroglobulin":1,
"Relapse":1,
"Thyroglobulin":2,
"NIFTP":1,
"cytology":3,
"molecular":1,
"variant":1,
"PTC":2,
"central neck dissection":1,
"ectopic nodal metastasis":1,
"lateral neck dissection":1,
"nodal metastasis":1,
"recurrence":1,
"Epstein–Barr virus infection":1,
"Herpesvirus":1,
"Thyroid nodules":3,
"Viral load":1,
"ACTH":1,
"T -cell":1,
"TSH":1,
"lymphoblastic lymphoma/leukemia":1,
"pituitary adenoma":1,
"Metastatic lymph node":1,
"Radiofrequency ablation (RFA)":1,
"lung metastasis":1,
"metastatic thyroid cancer":1,
"multikinase inhibitor (MKI) therapy":1,
"overall survival (OS)":1,
"radioactive iodine-refractory thyroid cancer":1,
"structural doubling time":1,
"Anterior commissure":1,
"Fetus":1,
"Human larynx":1,
"Thyroid cartilage":2,
"Vocal folds":1,
"Africa":1,
"blacks":1,
"non-Hispanic":1,
"proportional incidence ratio":1,
"sub-Saharan":1,
"fine needle aspiration":2,
"hobnail variant":1,
"IMMUNOCYTOCHEMISTRY":1,
"NEOPLASMS":2,
"fine needle aspiration (FNA)":1,
"micronuclei":1,
"nuclear buds":1,
"Hürthle cell variant":1,
"neck mass":1,
"parotid gland":1,
"5-aza-2′-deoxycytidine":1,
"NGFR":1,
"everolimus":1,
"mTOR":1,
"medullary thyroid cancer":3,
"neurotrophin pathway":1,
"Goiter":1,
"Hashimoto thyroiditis":1,
"Hyperthyroidism":3,
"Hypothyroidisms":1,
"Mammographic density":1,
"cancer":6,
"precision":1,
"radionuclide":1,
"therapy":1,
"Polidocanol injection":1,
"Predominantly cystic thyroid nodules":1,
"Sclerotherapy":1,
"lymph node":1,
"metastasis":2,
"mouse":1,
"double slide view":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"interobserver reproducibility":1,
"second opinion":1,
"thyroid fine needle aspirates":1,
"endoscopic thyroidectomy":2,
"minimally invasive surgery":1,
"retroauricular thyroidectomy":1,
"robotic thyroidectomy":2,
"transaxillary":1,
"DTC":1,
"comorbidities":1,
"population based":1,
"quality of life":1,
"thyroid symptoms":1,
"BMT":1,
"brain tumors":1,
"endocrinology":2,
"late effects of cancer treatment":1,
"outcomes research":1,
"2-hydroxylated estradiol":1,
"4-hydroxylated estradiol":1,
"UDP-glucuronosyltransferase (UGT)":1,
"estradiol":1,
"estrogen homeostasis":1,
"estrogen metabolism":1,
"noninvasive follicular tumor with papillary like nuclear features":1,
"papillae":1,
"cost-effectiveness":1,
"radioiodine refractory":1,
"treatment":1,
"value-based":1,
"Diagnosis":5,
"Endocrine system":1,
"Fine-needle aspiration biopsy":1,
"Gene mutation":2,
"circulating biomarkers":1,
"surveillance":1,
"atypia of undetermined significance":1,
"biopsy":2,
"fine-needle":1,
"meta-analysis":3,
"neoplasm":1,
"case-control":1,
"exposure":1,
"iodine":1,
"adolescent and young adult":1,
"epidemiology":2,
"pediatric":1,
"population-based":1,
"thyroid carcinoma":4,
"gene classifier":1,
"in vitro diagnostic test":1,
"indeterminate thyroid nodules":1,
"qPCR":2,
"Biological dosimetry":1,
"Chromosomal aberrations":1,
"Dose-rate effect":1,
"Elastography":1,
"Fine-needle aspiration":3,
"Epithelial–mesenchymal transition":1,
"HNF4α":1,
"Liver stem cells":1,
"Snail":1,
"Tg737":1,
"18F–DOPA":1,
"18F–FDG":1,
"68Ga-DOTANOC":1,
"68Ga-DOTATATE":1,
"68Ga-DOTATOC":1,
"Foregut-NET":1,
"Hindgut-NET":1,
"Hyperinsulism in infants":1,
"Midgut-NET":1,
"Neuroendocrine neoplasms":1,
"Neuroendocrine tumours":1,
"Paraganglioma":1,
"Pet/Ct":1,
"Pheochromoacytoma":1,
"Thyroid medullary cancer":1,
"5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine (PubChem CID: 5481276)":1,
"Drug delivery":1,
"PHBV":1,
"PLGA":1,
"Photodynamic therapy":1,
"Photosensitizer":1,
"Polymer-lipid-PEG nanoparticles":1,
"Apoptosis":4,
"Hepatocellular carcinoma":2,
"PIM1":1,
"Physcion 8-O-β-glucopyranoside":1,
"Migration and invasion":1,
"Mitochondrial membrane potential":1,
"Niclosamide":1,
"cardiovascular mortality":1,
"ovarian cancer":1,
"women's health":1,
"Cancer de la thyroïde":1,
"Case-control study":1,
"Dosimetric reconstruction":1,
"Perception des risques":1,
"Radiation risk perception":1,
"Reconstructions dosimétriques":1,
"Étude cas-témoins":1,
"liquid-based cytology":1,
"malignancies":1,
"malignant histotypes":1,
"pediatric patients":1,
"thyroid lesions":1,
"Ductal invasive breast carcinoma":1,
"Image analysis":1,
"Immunohistochemistry":6,
"Thyroid hormone receptor alpha":1,
"Tissue expression":1,
"Tri-iodothyronine":1,
"Laryngectomy":1,
"Squamous Cell Carcinoma":1,
"Thyroidectomy":5,
"Tyrosine kinase inhibitors":1,
"anaplastic thyroid cancer":2,
"cabozantinib":2,
"differentiated":1,
"lenvatinib":2,
"medullary":1,
"multikinase inhibitors":1,
"sorafenib":2,
"vandetanib":1,
"Adhesion molecule":1,
"VSIG1":1,
"gastric cancer":1,
"immunoglobulin superfamily":1,
"lung cancer":1,
"microRNA":1,
"nodules":1,
"iodine-131":1,
"second primary cancer":1,
"well-differentiated thyroid cancer":1,
"Papillary cancer":1,
"Prediction":1,
"TERT promoter":1,
"Bethesda System":1,
"Cyst fluid only":1,
"Non-diagnostic":1,
"Unsatisfactory":1,
"Cardiac risk":1,
"Medullary thyroid carcinoma":2,
"Pharmacodynamics exposure–response":1,
"Pharmacokinetics":1,
"QTc":1,
"subxiphoid approach":1,
"thoracoscopic surgery":1,
"thymectomy":1,
"video-assisted thoracic surgery":1,
"RET inhibitors":1,
"hit-to-lead":1,
"kinases":1,
"pyridines":1,
"pyrimidines":1,
"Long noncoding RNA H19":1,
"MicroRNA Let7a":1,
"Prognosis":4,
"familial":1,
"ATA guidelines":1,
"thyroid ultrasound":1,
"Early tumor shrinkage":1,
"ALDH1":1,
"CD133":1,
"CD24":1,
"CD44":1,
"Cancer stem cell":1,
"Thyroid neoplasms":10,
"Minimally invasive":1,
"Robotic parathyroidectomy":1,
"TOETVA":1,
"TONS":1,
"TORT":1,
"Transoral endoscopic thyroidectomy vestibular approach":1,
"Transoral thyroidectomy":1,
"Mortality":2,
"Neoplasm staging":1,
"TNM staging":1,
"Cholangiocarcinoma":1,
"Hepatitis C virus":1,
"Oral squamous cell cancer":1,
"Pancreatic adenocarcinoma":1,
"Papillary thyroid cancer":2,
"Renal/kidney cancer":1,
"Endocrine":1,
"Extrahepatic manifestations":1,
"Hepatitis C":1,
"Idiopathic thrombocytopenic purpura":1,
"Pulmonary":1,
"Chemical labeling":1,
"DNA and RNA formylation":1,
"In-tube solid-phase microextraction":1,
"Ultra high performance liquid chromatography - tandem mass spectrometry analysis":1,
"Computer vision":1,
"Convolutional neural network":1,
"Deep learning":1,
"Fine-tuning":1,
"Machine learning":1,
"Chimeric A2M-ALK gene":1,
"Fetal lung interstitial tumor":1,
"Inflammatory myofibroblastic tumor":1,
"Reverse-transcription polymerase chain reaction":1,
"Biomarker":4,
"Carcinoma":2,
"Follicular":1,
"Mass spectrometry":1,
"Therapeutic target":1,
"Dental artifact":1,
"Dual-energy CT":1,
"Head and neck squamous cell carcinoma":1,
"Lymphadenopathy":1,
"Material decomposition iodine maps":1,
"Spectral Hounsfield unit attenuation curves":1,
"Thyroid cartilage invasion":2,
"Virtual monochromatic images":1,
"DNA damage":1,
"Zucker rat":1,
"obesity":1,
"γ-H2AX":1,
"Taste alteration":1,
"antidepressants":1,
"dysgeusia":1,
"Adverse events":1,
"endocrine toxicity":1,
"immune checkpoint inhibitors":2,
"immunotherapy":1,
"thyroid dysfunction":1,
"Extreme learning machine":1,
"Feature selection":1,
"Medical diagnosis":1,
"Sonographic features":1,
"Bladder":1,
"NEC":1,
"pathological features":1,
"cancer susceptibility":1,
"clonal selection":1,
"personalized medicine":1,
"tumor heterogeneity":1,
"Composite pheochromocytoma/paraganglioma":1,
"Ganglioneuroma":1,
"MEN 2":1,
"farnesoid X receptor":1,
"thyroid neoplasia":1,
"calcium and bone":1,
"general surgery":1,
"head and neck surgery":1,
"SHBG":1,
"endogenous sex hormone":1,
"male":1,
"metastases":1,
"molecular biology":1,
"oncogenes":1,
"Chinese patients":1,
"breast metastasis":1,
"gastric carcinoma":1,
"BRAF V600E":2,
"Fas/FasL":1,
"SW579":1,
"human thyroid squamous cell carcinoma":1,
"hyperoside":1,
"survivin":1,
"Surgical procedures, operative":2,
"Robotics":1,
"Thyroid diseases":2,
"Ablation techniques":1,
"Complication":1,
"Reoperative surgery":1,
"Surgical strategy":1,
"Endoscopy":1,
"Mouth":1,
"Neck dissection":3,
"Factor analysis, statistical":2,
"Lymphatic metastasis":2,
"Galectin-3":2,
"fine needle aspiration (FNAC)":1,
"Antibody clones":1,
"CD43":1,
"Non-hematologic malignancies":1,
"B-cell lymphoma-2":1,
"Bcl-2-associated X protein":1,
"Prunella vulgaris":1,
"anti-proliferative":1,
"caspase-3":1,
"well-differentiated thyroid carcinoma":1,
"Pleural angiosarcoma":1,
"Radiometabolic therapy":1,
"Ethnicity":1,
"insurance coverage":1,
"Cancer registry":1,
"China":1,
"Incidence":2,
"Bavaria":1,
"disease":1,
"groundwater":1,
"liver":1,
"odds ratio":1,
"public health":1,
"relative risk":1,
"uranium":1,
"RAI (radioiodine) ablation":1,
"molecular diagnostics":1,
"multi kinase inhibitors":1,
"thyroid surgery":1,
"Graves′ disease":1,
"Hashimoto disease":1,
"Thyroid imaging reporting and data system":1,
"Utrasonography":1,
"Tumor recurrence":1,
"Kindler's syndrome, Breast Cancer, Oman, The Royal Hospital, BC, KS":1,
"Intracystic growth":1,
"Mesonephric adenocarcinoma":1,
"Uterine corpus":1,
"RET proto-oncogene":1,
"Calcitonin":2,
"microRNA-323":1,
"FFPE":1,
"Anaplastic thyroid carcinoma":1,
"CD133 antigen":1,
"Phosphoinositide-3-kinase":1,
"Sodium":1,
"iodide symporter":1,
"Survival":2,
"Iran":1,
"cancer detection":1,
"head and neck cancer":1,
"hyperspectral imaging":1,
"image classification":1,
"image quantification":1,
"image-guided surgery":1,
"label-free":1,
"tumor margin assessment":1,
"ecological study":1,
"nuclear sites":1,
"acid-triggered release":1,
"doxorubicin":1,
"silicon dioxide nanoparticle":1,
"Drug repurposing":1,
"Ribavirin":1,
"eIF4E":1,
"β-catenin":1,
"VCAN":1,
"miR-135a-5p":1,
"Pentastomida":1,
"bisphosphonate-associated osteonecrosis of the jaw (BRONJ)":1,
"osteonecrosis":1,
"parasite":1,
"Adenoid cystic carcinoma":1,
"Trachea":1,
"Diagnostic agreement":1,
"Evidence based":1,
"Survival times":1,
"CT":1,
"Computed tomography":1,
"US":1,
"early detection of cancer":1,
"stage":1,
"Mutation burden":1,
"Neoantigen":1,
"Tumor microenvironment immune type":1,
"mRNA sequencing":1,
"Esophageal neuroendocrine carcinoma":1,
"esophageal carcinoid":1,
"esophageal neoplasm":1,
"neuroendocrine tumors":1,
"Anatomical anomaly":1,
"Lingual artery":1,
"Superior thyroid artery":1,
"Histology":1,
"Pathology":1,
"Dry mouth":1,
"Nuclear medicine imaging":1,
"Radioiodine treatment":1,
"Non-functional parathyroid carcinoma":1,
"double parathyroid carcinoma":1,
"thyroid papillary carcinoma":1,
"Pyruvate kinases isoenzyme M2":1,
"activator":1,
"carboxamide":1,
"phenolic compound":1,
"sulfonamide":1,
"Chemotherapy":1,
"cisplatin":1,
"etoposide":1,
"neuroendocrine tumor":1,
"IHC":1,
"CXXC5":1,
"chromogenic in&nbsp":1,
"situ hybridization":1,
"high-grade prostatic intra-epithelial neoplasia":1,
"proliferative inflammatory atrophy":1,
"prostatic adenocarcinoma":1,
"BRCAlike":1,
"DDR":1,
"HR":1,
"PARPi":1,
"TKi":1,
"synthetic-lethal":1,
"targeted-therapy":1,
"Sanger sequencing":1,
"PSM":1,
"SEER":1,
"oxyphilic cell papillary thyroid carcinoma":1,
"circulating epithelial cells":1,
"epithelial cell adhesion molecule":1,
"podoplanin":1,
"therapeutic response":1,
"lymph node posterior to right recurrent laryngeal nerve":1,
"risk factors":2,
"liver transplantation":1,
"selection":1,
"transarterial chemoembolization":1,
"Graves Disease":1,
"functional thyroid carcinoma":1,
"radioactive iodine":1,
"cN0":1,
"lymph node metastasis":1,
"spectral Doppler":1,
"superb microvascular imaging":1,
"shear wave elastography":1,
"carotid sheath":1,
"99mTc-sestamibi":1,
"Parathyroid carcinoma":1,
"SPECT/CT":1,
"Colon cancer":1,
"Virchow lymph node dissection":1,
"Virchow lymph node metastasis":1,
"cytokeratin 19":1,
"diagnostic accuracy":1,
"hector battiforamesothelial antigen-1":1,
"Ectopic thyroid tissue":1,
"adrenal gland":1,
"immnunohistochemistry":1,
"serum miR-26a":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年8月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
